1)Grice EA, Segre JA. The human microbiome: our second genome. Annu Rev Genomics Hum Genet. 2012; 13: 151-70
|
|
|
2)Savage DC. Microbial ecology of the gastrointestinal tract. Annu Rev Microbiol. 1977; 31: 107-33
|
|
|
3)Qin J, Li R, Raes J, et al. A human gut microbial gene catalogue established by metagenomic sequencing. Nature. 2010; 464: 59-65
|
|
|
4)Human Microbiome Project Consortium. A framework for human microbiome research. Nature. 2012; 486: 215-21
|
|
|
5)服部正平, 大島健志朗, 須田 亙. 細胞工学. 別冊次世代シークエンサー 目的別アドバンストメソッド. 2012; 9: 160-8
|
|
|
6)森 宙史, 林 哲也, 黒川 顕. メタゲノム研究の最前線 454とメタゲノム解析. 蛋白質 核酸 酵素. 2009; 54: 1264-70
|
|
|
7)Human Microbiome Project Consortium. Structure, function and diversity of the healthy human microbiome. Nature. 2012; 486: 207-14
|
|
|
8)Turnbaugh PJ, Hamady M, Yatsunenko T, et al. A core gut microbiome in obese and lean twins. Nature. 2009; 457: 480-4
|
|
|
9)Yatsunenko T, Rey FE, Manary MJ, et al. Human gut microbiome viewed across age and geography. Nature. 2012; 486: 222-7
|
|
|
10)Arumugam M, Raes J, Pelletier E, et al. Enterotypes of the human gut microbiome. Nature. 2011; 473: 174-80
|
|
|
11)Wu GD, Chen J, Hoffmann C, et al. Linking long-term dietary patterns with gut microbial enterotypes. Science. 2011; 334: 105-8
|
|
|
12)Hehemann JH, Correc G, Barbeyron T, et al. Transfer of carbohydrate-active enzymes from marine bacteria to Japanese gut microbiota. Nature. 2010; 464: 908-12
|
|
|
13)Le Chatelier E, Nielsen T, Qin J, et al. Richness of human gut microbiome correlates with metabolic markers. Nature. 2013; 500: 541-6
|
|
|
14)Vijay-Kumar M, Aitken JD, Carvalho FA, et al. Metabolic syndrome and altered gut microbiota in mice lacking Toll-like receptor 5. Science. 2010; 328: 228-31
|
|
|
15)Frank DN, St Amand AL, Feldman RA, et al. Molecular-phylogenetic characterization of micro-bial community imbalances in human inflammatory bowel diseases. Proc Natl Acad Sci U S A. 2007; 104: 13780-5
|
|
|
16)Sokol H, Pigneur B, Watterlot L, et al. Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients. Proc Natl Acad Sci U S A. 2008; 105: 16731-6
|
|
|
17)Qin J, Li Y, Cai Z, et al. A metagenome-wide association study of gut microbiota in type 2 diabetes. Nature. 2012; 490: 55-60
|
|
|
18)Karlsson FH, Tremaroli V, Nookaew I, et al. Gut metagenome in European women with normal, impaired and diabetic glucose control. Nature. 2013; 498: 99-103
|
|
|
19)Gardner SE, Hillis SL, Heilmann K, et al. The neuropathic diabetic foot ulcer microbiome is associated with clinical factors. Diabetes. 2013; 62: 923-30
|
|
|
20)van Nood E, Vrieze A, Nieuwdorp M, et al. Duodenal infusion of donor feces for recurrent Clostridium difficile. N Engl J Med. 2013; 368: 407-15
|
|
|
21)Smith MI, Yatsunenko T, Manary MJ, et al. Gut microbiomes of Malawian twin pairs discordant for kwashiorkor. Science. 2013; 339: 548-54
|
|
|
22)Pragman AA, Kim HB, Reilly CS, et al. The lung microbiome in moderate and severe chronic obstructive pulmonary disease. PLoS One. 2012; 7: e47305
|
|
|
23)Marri PR, Stern DA, Wright AL, et al. Asthma-associated differences in microbial composition of induced sputum. J Allergy Clin Immunol. 2013; 131: 346-52.e1-3
|
|
|
24)Vaziri ND, Wong J, Pahl M, et al. Chronic kidney disease alters intestinal microbial flora. Kidney Int. 2013; 83: 308-15
|
|
|
25)Wang F, Jiang H, Shi K, et al. Gut bacterial translocation is associated with microinflammation in end-stage renal disease patients. Nephrology. 2012; 17: 733-8
|
|
|
26)Artese HP, de Sousa CO, Torres MC, et al. Effect of non-surgical periodontal treatment on the subgingival microbiota of patients with chronic kidney disease. Braz Oral Res. 2012; 26: 366-72
|
|
|
27)Hotta O, Miyazaki M, Furuta T, et al. Tonsillectomy and steroid pulse therapy significantly impact on clinical remission in patients with IgA nephropathy. Am J Kidney Dis. 2001; 38: 736-43
|
|
|
28)Xie Y, Nishi S, Ueno M, et al. The efficacy of tonsillectomy on long-term renal survival in patients with IgA nephropathy. Kidney Int. 2003; 63: 1861-7
|
|
|
29)Komatsu H, Fujimoto S, Hara S, et al. Effect of tonsillectomy plus steroid pulse therapy on clinical remission of IgA nephropathy: a controlled study. Clin J Am Soc Nephrol. 2008; 3: 1301-7
|
|
|
30)Suzuki S, Fujieda S, Sunaga H, et al. Synthesis of immunoglobulins against Haemophilus parainfluenzae by tonsillar lymphocytes from patients with IgA nephropathy. Nephrol Dial Transplant. 2000; 15: 619-24
|
|
|
31)Koyama A, Sharmin S, Sakurai H, et al. Staphylococcus aureus cell envelope antigen is a new candidate for the induction of IgA nephropathy. Kidney Int. 2004; 66: 121-32
|
|
|
32)Jensen A, Fagö-Olsen H, Sørensen CH, et al. Molecular mapping to species level of the tonsillar crypt microbiota associated with health and recurrent tonsillitis. PLoS One. 2013; 8: e56418
|
|
|